Circulating level of fatty acid‐binding protein 4 is an independent predictor of metabolic dysfunction‐associated fatty liver disease in middle‐aged and elderly individuals

AIMS/INTRODUCTION: Metabolic dysfunction‐associated fatty liver disease (MAFLD), defined as hepatosteatosis with type 2 diabetes mellitus, overweight/obesity or metabolic dysregulation, has been proposed as a new feature of chronic liver disease. Fatty acid‐binding protein 4 (FABP4) is expressed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Marenao, Takahashi, Satoko, Higashiura, Yukimura, Sakai, Akiko, Koyama, Masayuki, Saitoh, Shigeyuki, Shimamoto, Kazuaki, Ohnishi, Hirofumi, Furuhashi, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077725/
https://www.ncbi.nlm.nih.gov/pubmed/34889064
http://dx.doi.org/10.1111/jdi.13735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077725/
https://www.ncbi.nlm.nih.gov/pubmed/34889064
http://dx.doi.org/10.1111/jdi.13735

Ejemplares similares